vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and SYNCHRONOSS TECHNOLOGIES INC (SNCR). Click either name above to swap in a different company.

SYNCHRONOSS TECHNOLOGIES INC is the larger business by last-quarter revenue ($42.0M vs $40.7M, roughly 1.0× PETMED EXPRESS INC). SYNCHRONOSS TECHNOLOGIES INC runs the higher net margin — 13.8% vs -26.0%, a 39.8% gap on every dollar of revenue. On growth, SYNCHRONOSS TECHNOLOGIES INC posted the faster year-over-year revenue change (-2.2% vs -23.3%). SYNCHRONOSS TECHNOLOGIES INC produced more free cash flow last quarter ($39.0M vs $-9.2M). Over the past eight quarters, SYNCHRONOSS TECHNOLOGIES INC's revenue compounded faster (0.7% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Synchronoss Technologies Inc develops cloud-based digital transformation, subscriber management and messaging solutions for global telecom operators and enterprise clients. Its core offerings support connectivity onboarding, IoT service enablement, with key markets spanning North America, Europe and Asia-Pacific.

PETS vs SNCR — Head-to-Head

Bigger by revenue
SNCR
SNCR
1.0× larger
SNCR
$42.0M
$40.7M
PETS
Growing faster (revenue YoY)
SNCR
SNCR
+21.0% gap
SNCR
-2.2%
-23.3%
PETS
Higher net margin
SNCR
SNCR
39.8% more per $
SNCR
13.8%
-26.0%
PETS
More free cash flow
SNCR
SNCR
$48.2M more FCF
SNCR
$39.0M
$-9.2M
PETS
Faster 2-yr revenue CAGR
SNCR
SNCR
Annualised
SNCR
0.7%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
PETS
PETS
SNCR
SNCR
Revenue
$40.7M
$42.0M
Net Profit
$-10.6M
$5.8M
Gross Margin
23.3%
79.4%
Operating Margin
-25.7%
14.0%
Net Margin
-26.0%
13.8%
Revenue YoY
-23.3%
-2.2%
Net Profit YoY
-1392.6%
201.7%
EPS (diluted)
$-0.50
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
SNCR
SNCR
Q4 25
$40.7M
Q3 25
$44.4M
$42.0M
Q2 25
$51.2M
$42.5M
Q1 25
$50.8M
$42.2M
Q4 24
$52.0M
$44.2M
Q3 24
$58.0M
$43.0M
Q2 24
$66.2M
$43.5M
Q1 24
$65.1M
$43.0M
Net Profit
PETS
PETS
SNCR
SNCR
Q4 25
$-10.6M
Q3 25
$-8.5M
$5.8M
Q2 25
$-34.2M
$-19.6M
Q1 25
$-11.6M
$-3.8M
Q4 24
$-707.0K
$7.9M
Q3 24
$2.3M
$-5.7M
Q2 24
$3.8M
$-494.0K
Q1 24
$-5.0M
$4.5M
Gross Margin
PETS
PETS
SNCR
SNCR
Q4 25
23.3%
Q3 25
28.0%
79.4%
Q2 25
28.1%
79.0%
Q1 25
29.9%
79.4%
Q4 24
31.0%
78.6%
Q3 24
32.3%
79.1%
Q2 24
28.8%
76.1%
Q1 24
29.3%
76.2%
Operating Margin
PETS
PETS
SNCR
SNCR
Q4 25
-25.7%
Q3 25
-18.9%
14.0%
Q2 25
-66.7%
16.1%
Q1 25
-11.9%
19.5%
Q4 24
-0.9%
16.5%
Q3 24
1.0%
12.8%
Q2 24
6.6%
9.9%
Q1 24
-5.9%
10.7%
Net Margin
PETS
PETS
SNCR
SNCR
Q4 25
-26.0%
Q3 25
-19.2%
13.8%
Q2 25
-66.7%
-46.1%
Q1 25
-22.9%
-9.0%
Q4 24
-1.4%
17.8%
Q3 24
4.0%
-13.3%
Q2 24
5.7%
-1.1%
Q1 24
-7.7%
10.4%
EPS (diluted)
PETS
PETS
SNCR
SNCR
Q4 25
$-0.50
Q3 25
$-0.41
$0.51
Q2 25
$-1.65
$-1.87
Q1 25
$-0.56
$-0.37
Q4 24
$-0.03
$0.75
Q3 24
$0.11
$-0.56
Q2 24
$0.18
$0.01
Q1 24
$-0.24
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
SNCR
SNCR
Cash + ST InvestmentsLiquidity on hand
$26.9M
$34.8M
Total DebtLower is stronger
$163.2M
Stockholders' EquityBook value
$32.8M
$55.4M
Total Assets
$88.0M
$278.2M
Debt / EquityLower = less leverage
2.95×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
SNCR
SNCR
Q4 25
$26.9M
Q3 25
$36.1M
$34.8M
Q2 25
$41.1M
$24.6M
Q1 25
$54.7M
$29.1M
Q4 24
$50.1M
$33.4M
Q3 24
$52.0M
$25.2M
Q2 24
$46.0M
$23.6M
Q1 24
$55.3M
$19.1M
Total Debt
PETS
PETS
SNCR
SNCR
Q4 25
Q3 25
$163.2M
Q2 25
$186.2M
Q1 25
$187.0M
Q4 24
$186.7M
Q3 24
$186.4M
Q2 24
$186.2M
Q1 24
$136.6M
Stockholders' Equity
PETS
PETS
SNCR
SNCR
Q4 25
$32.8M
Q3 25
$43.1M
$55.4M
Q2 25
$51.5M
$49.4M
Q1 25
$85.1M
$35.4M
Q4 24
$96.2M
$29.8M
Q3 24
$96.4M
$35.3M
Q2 24
$93.5M
$30.6M
Q1 24
$96.7M
$24.0M
Total Assets
PETS
PETS
SNCR
SNCR
Q4 25
$88.0M
Q3 25
$100.3M
$278.2M
Q2 25
$109.8M
$291.4M
Q1 25
$148.7M
$293.3M
Q4 24
$144.8M
$293.8M
Q3 24
$146.0M
$299.7M
Q2 24
$152.7M
$295.7M
Q1 24
$169.9M
$298.5M
Debt / Equity
PETS
PETS
SNCR
SNCR
Q4 25
Q3 25
2.95×
Q2 25
3.77×
Q1 25
5.28×
Q4 24
6.27×
Q3 24
5.28×
Q2 24
6.08×
Q1 24
5.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
SNCR
SNCR
Operating Cash FlowLast quarter
$-9.2M
$39.4M
Free Cash FlowOCF − Capex
$-9.2M
$39.0M
FCF MarginFCF / Revenue
-22.7%
92.9%
Capex IntensityCapex / Revenue
0.1%
0.9%
Cash ConversionOCF / Net Profit
6.77×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$53.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
SNCR
SNCR
Q4 25
$-9.2M
Q3 25
$-2.2M
$39.4M
Q2 25
$-12.3M
$2.3M
Q1 25
$7.0M
$293.0K
Q4 24
$-1.2M
$13.1M
Q3 24
$7.4M
$3.4M
Q2 24
$-8.5M
$11.3M
Q1 24
$7.1M
$527.0K
Free Cash Flow
PETS
PETS
SNCR
SNCR
Q4 25
$-9.2M
Q3 25
$-4.8M
$39.0M
Q2 25
$-13.6M
$2.0M
Q1 25
$4.6M
$-31.0K
Q4 24
$-1.9M
$12.2M
Q3 24
$6.1M
$3.2M
Q2 24
$-9.2M
$10.9M
Q1 24
$5.9M
$10.0K
FCF Margin
PETS
PETS
SNCR
SNCR
Q4 25
-22.7%
Q3 25
-10.8%
92.9%
Q2 25
-26.5%
4.6%
Q1 25
9.1%
-0.1%
Q4 24
-3.7%
27.6%
Q3 24
10.6%
7.5%
Q2 24
-13.9%
25.2%
Q1 24
9.0%
0.0%
Capex Intensity
PETS
PETS
SNCR
SNCR
Q4 25
0.1%
Q3 25
5.9%
0.9%
Q2 25
2.5%
0.8%
Q1 25
4.7%
0.8%
Q4 24
1.5%
1.9%
Q3 24
2.2%
0.3%
Q2 24
1.0%
0.9%
Q1 24
1.9%
1.2%
Cash Conversion
PETS
PETS
SNCR
SNCR
Q4 25
Q3 25
6.77×
Q2 25
Q1 25
Q4 24
1.66×
Q3 24
3.18×
Q2 24
-2.27×
Q1 24
0.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

SNCR
SNCR

Subscription Services$39.4M94%
Professional Services$2.6M6%

Related Comparisons